Herpes simplex virus type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication

Virology

Volumn 247, Issue 2, 1998, Pages 212-222

  Patel, Amit ^a   Hanson, Julie ^a   McLean, Tim I ^a   Olgiate, Jennifer ^a   Hilton, Melissa ^a   Miller, William E ^a   Bachenheimer, Steven L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; HERPES SIMPLEX VIRUS, TYPE 1 PROTEIN ICP4; I KAPPA B; I KAPPA B BETA; ICP27 PROTEIN, HUMAN HERPESVIRUS 1; IMMEDIATE EARLY PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; REPRESSOR PROTEIN;

ARTICLE; HERPES SIMPLEX VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; CELL CULTURE; CELL NUCLEUS; HUMAN; METABOLISM; PHYSIOLOGY; TRANSACTIVATION; TRANSPORT AT THE CELLULAR LEVEL;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1;

BIOLOGICAL TRANSPORT; CELL NUCLEUS; DNA-BINDING PROTEINS; HERPESVIRUS 1, HUMAN; HUMANS; I-KAPPA B PROTEINS; IMMEDIATE-EARLY PROTEINS; NF-KAPPA B; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0032129268     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9243     Document Type: Article

References (71)

1. Baeurerle P., Baltimore D. Activation of DNA binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell. 53:1988;211-217.
2. Baldwin A. S. Jr. Annu. Rev. Immunol. 14:1996;649-681.
3. 01. Mol. Cell. Biol. 2:1991;4943-4951.
4. Beg A. A., Baltimore D. An essential role for NF-κB in preventing TNFα-induced cell death. Science. 274:1996;782-784.
5. Beg A., Finco T., Nantermet P., Baldwin A. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: A mechanism of NF-κB activation. Mol. Cell. Biol. 13:1993;3301-3310.
6. Berghe W. V., Plaisance S., Boone E., De Bosscher K., Schmitz M. L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:1998;3285-3290.
7. Brockman J. A, Scherer D. C., McKinsey T. A., Hall S. M., Qi X., Lee W. Y., Ballard D. W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:1995;2809-2818.
8. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκB-α proteolysis by site-specific signal-induced phosphorylation. Science. 267:1995;1485-1488.
9. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D. V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
10. Chiao P. J., Miyamoto S., Verma I. M. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA. 91:1994;28-32.
11. Cheshire J. L., Baldwin A. S. Jr. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol. Cell. Biol. 17:1997;6746-6754.
12. -. Proc. Natl. Acad. Sci. USA. 92:1995;10516-10520.
13. Chuang C. F., Ng S. Y. Functional divergence of the MAP kinase pathway, ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346:1994;229-234.
14. Devergne O., Hatzivassiliou E., Izumi K. M., Kaye K. M., Kleijnen M. F., Kieff E., Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation. Mol. Cell. Biol. 16:1996;7098-7108.
15. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandl E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
16. Finco T. S., Baldwin A. S. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires raf-1. J. Biol. Chem. 268:1993;17676-17679.
17. Finco T. S., Westwick K. K., Norris J. L., Begg A. A., Der C. J., Baldwin A. S. Jr. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272:1997;24113-24116.
18. Frazier D. P., Cox D., Godshalk E. M., Schaffer P. A. The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells. J. Virol. 70:1996;7424-7432.
19. Fuller A. O., Santos R., Spear P. G. Potent neutralizing antibodies to gH of herpes simplex virus do not block attachment but prevent penetration of virus. J. Virol. 63:1989;3535-3543.
20. Gao M., Knipe D. M. Potential role of herpes simplex virus ICP8 replication protein in stimulation of late gene expression. J. Virol. 65:1991;2666-2675.
21. Garcin D., Michal Y., Jault F., Lyon M., Lenoir G., Jacquemont B. Inhibition of HSV-1 multiplication in rat embryo fibroblasts constitutively expressing the EJ-ras oncogene. Virology. 179:1990;208-216.
22. Gimble J. M., Duh E., Ostrove J. M., Gendelman H. E., Max E. E., Rabson A. B. Activation of the human immunodeficiency virus long-terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-κB/core enhancer sequence. J. Virol. 62:1988;4104-4112.
23. Gorman I. H., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
24. Hardy W. F., Sandri-Goldin R. M. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 68:1994;7790-7799.
25. Highlander S., Sutherland S. L., Gage P. J., Johnson D. C., Levine M., Glorioso J. C. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J. Virol. 61:1987;3356-3364.
26. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1996;411-415.
27. Hilton M. J., Mounghane D., McLean T., Contractor N. V., O'Neil J., Carpenter K., Bachenheimer S. L. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor. Virology. 213:1995;624-638.
28. Huen D. S., Henderson S. A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein 1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector genes in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
29. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA. 91:1994;6288-6292.
30. Lee F. S., Hagler J., Chen Z. J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
31. Lehming N., Thanos D., Brickman J. M., Ma J., Mainiatis T., Ptashne M. An HMG-like protein can switch a transcriptional activator to a repressor. Nature. 371:1994;175-179.
32. Leib D. A., Bogard C. L., Kosz-Vnenchak M., Hicks K. A., Coen D. M., Knipe D. M., Schaffer P. A. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latency state with reduced frequency. J. Virol. 63:1989;2893-2900.
33. Malinin N. L., Boldin M. P., Kovalenko A. V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
34. Maran A., Maitra R. K., Kumar A., Dong B., Xiao W., Li G., Williams B. R. G., Torrance P. F., Silverman R. H. Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science. 265:1994;789-792.
35. Margolis D. M., Rabson A. B., Straus S. E., Ostrove J. M. Transactivation of the HIV LTR by HSV-1 immediate-early genes. Virology. 186:1992;788-791.
36. Marsters S. A., Ayers T. M., Skubatch M., Gray C. L., Rothe M., Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NFκB and AP-1. J. Biol. Chem. 272:1997;14029-14032.
37. Miller W. E., Cheshire J. L., Raab-Traub N. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression. Mol. Cell. Biol. 18:1998;2835-2844.
38. Miller W. E., Mosialos G., Kieff E., Raab-Traub N. Epstein-Barr virus LMP-1 induction of epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB activation. J. Virol. 71:1997;586-594.
39. Mitchell T., Sugden B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:1995;2968-2976.
40. Montgomery R. I., Warner M. S., Lum B. J., Spear P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
41. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
42. Naumann M., Scheidereit C. Activation of NF-κBin vivo. EMBO J. 13:1994;4597-4607.
43. Oroskar A. A., Read G. S. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63:1989;1897-1906.
44. Pahl H. L., Baeuerle P. A. The ER-overload response: activation of NF-κB. Trends Biochem. Sci. 22:1997;63-67.
45. Pahl H. L., Sester M., Burgert H.-G., Baeuerle P. A. Activation of transcription factor NF-κB by the adenovirus E3/19K protein requires its ER retention. J. Cell Biol. 132:1996;511-522.
46. Paine E., Scheinman R. I., Baldwin A. S. Jr., Raab-Traub N. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J. Virol. 69:1995;4572-4576.
47. Palombella V. J., Rando O. J., Goldberg A. L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:1994;773-785.
48. Read, G. S. 1997, Control of mRNA stability during herpes simplex virus infections, In, mRNA Metabolism and Post-transcriptional Gene Regulation, 311, 321, Wiley-Liss, Inc. New York, NY.
49. Read G. S., Frenkel N. Herpes simplex virus mutants defective in virion-associated shutoff of host protein synthesis and exhibiting abnormal synthesis of alpha (immediate-early) polypeptides. J. Virol. 46:1983;498-512.
50. Róegnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
51. Rice S. A., Knipe D. M. Genetic evidence for two distinct transactivation functions of the herpes simplex virus α protein ICP27. J. Virol. 64:1990;1704-1715.
52. Roizman, B. Sears, A. E. 1996, Herpes simplex viruses and their replication, In, Virology, B. N. FieldsD. M. KnipeP. M. Howley, 2231, 2295, Lippincott-Raven Publishers, Philadelphia, PA.
53. Rong B. L., Libermann T. A., Kogawa K., Ghosh S., Cao L.-X., Pavan-Langston D., Dunkel E. C. HSV-1 inducible proteins bind to NF-κB-like sites in the HSV-1 genome. Virology. 189:1992;750-756.
54. Sambucetti L. C., Cherrington J. M., Wilkinson G. W., Mocarski E. S. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:1989;4251-4258.
55. Scherer D. C., Brockman J. A., Chen Z., Maniatis T., Ballard D. W. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA. 92:1995;11259-11263.
56. Shepard A. A., DeLuca N. A. Activities of heterodimers composed of DNA-binding and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4. J. Virol. 65:1991;299-307.
57. Smibert C. A., Smiley J. R. Differential regulation of endogenous and transduced β-globin genes during infection of erythroid cells with a herpes simplex virus type 1 recombinant. J. Virol. 64:1990;3882-3894.
58. Strelow L. I., Leib D. A. Role of the virion host shutoff (vhs. J. Virol. 69:1995;6779-6786.
59. Suyang H., Phillips R., Douglas I., Ghosh S. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:1996;5444-5449.
60. Thanos D., Maniatis T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell. 71:1992;777-789.
61. Thompson J. E., Phillips R. J., Erdjument-Bromage H., Tempst P., Ghosh S. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:1995;573-582.
62. Traenckner E. B.-M., Wilk S., Baeuerle P. A. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:1994;5433-5441.
63. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNFα-induced apoptosis by NF-κB. Science. 274:1996;787-789.
64. Verma I. M., Stevenson J. K., Schwarz E. M., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes and Dev. 9:1995;2723-2735.
65. Wang C.-Y., Mayo M. W., Baldwin A. S. Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
66. Xia K., Knipe D. M., DeLuca N. A. Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication. J. Virol. 70:1996;1050-1060.
67. Yager D. R., Bachenheimer S. L. Synthesis and metabolism of cellular transcripts in HSV-1 infected cells. Virus Genes. 1:1988;135-148.
68. Yurochko A. D., Hwang E.-S., Rasmussen L., Keay S., Pereira L., Huang E.-S. The human cytomegalovirus UL55(gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71:1997a;5051-5059.
69. Yurochko A. D., Mayo M. W., Poma E. E., Baldwin A. S. Jr., Huang E.-S. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J. Virol. 71:1997b;4638-4648.
70. Yoza B. K., Hu J. Y. Q., McCall C. E. Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1β and NF-κB activation, but not NF-κB nuclear translocation. J. Biol. Chem. 271:1996;18306-18309.
71. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.